期刊文献+

阿尔茨海默病血清蛋白质组学研究 被引量:4

Proteomic study on serum in patients with Alzheimer' s disease
原文传递
导出
摘要 目的对6例阿尔茨海默病(AD)患者血清二向电泳前预处理,去除高丰度蛋白,增加低丰度蛋白的检测效果。方法采用去除白蛋白球蛋白试剂盒对受试者血清进行预处理.然后二向电泳,结合质谱仪分析来鉴定兴趣蛋白质。结果通过对比AD组和对照组二向电泳图.得到24个差异蛋白质点,对这些差异蛋白点进行质谱仪分析,发现6例AD病人血清触珠蛋白表达增高,而只有3例AD病人血清转甲状腺素蛋白㈣表达降低。结论对AD血清二向电泳前预处理可以提高低丰度蛋白的检测效果,提示该方法可很好地用于鉴别AD血清生物标记。 Objective To pretreat the patients with Alzheimer's disease (AD) prior to two-dimensional gel electrophoresis (2-DE) by removing the high-abundance proteins from serum samples so as to enhance the detection of low-abundance proteins. Methods A pretrcatment with ProteoPrep Blue Albumin Depletion Kit was performed on the sera ofAD (n=6) and control (n=6 healthy elders) groups, and then 2-DE coupled to mass spectrometry (MS) was employed to identify the proteins of interest. Results After the 2-D electropherograms of AD patients and controls were compared, 24 differential protein spots were found and successfully identified as haptoglobin and transthyretin. The expression of haptoglobin was elevated in the sera of 6 AD cases, and the expression of transthyretin was decreased only in the sera of 3 AD cases. Conclusion The pretrcatment of AD serum prior to 2-DE can improve the detection effect of low-abundance proteins, indicating that it would benefit the identification ofbiomarkers in AD serum.
出处 《中华神经医学杂志》 CAS CSCD 2007年第3期297-300,共4页 Chinese Journal of Neuromedicine
基金 国家自然科学基金资助项目(39370246) “九五”国家医学科技攻关项目(96-906-05-07)
关键词 阿尔茨海默病 蛋白质组学 质谱仪 触珠蛋白 转甲状腺素蛋白 Alzheimer' s disease Proteomics Mass spectrometry Haptoglobin Transthyretin
  • 相关文献

参考文献12

  • 1de Ferrari GV, Inestrosa NC. Wnt signaling function in Alzheimer's disease[J]. Brain Res Brain Res Rev, 2000, 33(1): 1-12.
  • 2Georgiou HM, Rice GE, Baker MS Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins[J]. Proteomics. 2001, 1 (12):1503-1506.
  • 3Zhang R, Barker L, Pinchev D. et al. Mining biomarkers in human sera using proteomic tools[J] Proteomics. 2004, 4: 244-256
  • 4Mattila KM, Pirttila T, Blennow K, et al. Altered blood-brain-barrier function in Alzheimer's disease?[J]. Acta Neurol Scand, 1994,89(3):192-198.
  • 5Elovaara I, Icen A, Palo J, et al. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis[J]. J Neurol Sci, 1985,70(1): 73-80.
  • 6Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin stimulated lipid peroxidation [J]. Biochim Biophys Acta, 1987,917(2): 219-223
  • 7Serot JM, Christmann D. Dubost T, et al. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry, 1997, 63(4):506-508
  • 8李雪华,李欣,徐守军,丁彦青.血清蛋白质组学研究中白蛋白和IgG去除方法的建立与评价[J].第一军医大学学报,2004,24(11):1233-1235. 被引量:11
  • 9沈新明,江培洲,黄华,李欣,姚开泰.运用双向聚丙烯酰胺凝胶电泳和图像软件分析TPA处理NIH3T3细胞前后的蛋白质表达谱差异[J].第一军医大学学报,2004,24(3):310-313. 被引量:4
  • 10Carro E. Trejo JL, Gomez-Isla T, et al. Serum insulin-like growth factor Ⅰ regulates brain amyloid-beta levels[J]. Nat Med, 2002, 8(12): 1390-1397.

二级参考文献19

  • 1刘耀波 见:汪家政 范明.变性条件下的凝胶电泳[A].见:汪家政,范明.蛋白质技术手册[C].北京:科学出版社,2001.77-110.
  • 2余应年 见:江希明 郑树 丁仁瑞.致癌因子及其分子生物学[A].见:江希明,郑树,丁仁瑞.肿瘤生物学[C].杭州:浙江科技出版社,1990.97-163.
  • 3Steel LF, Shumpert D, Trotter M, et al. A strategy for the comparative analysis of serum proteom es for the discovery of biomarkers for hepatocellular carcinoma [ J ]. Proteomics, 2003, 3(5): 601-9.
  • 4Rai AJ, Zhang Z, Rosenzweig J, et al. Proteomic approaches to tumor marker discovery[J]. Arch Pathol Lab Med, 2002, 126(12):1518-26.
  • 5Wang YY, Cheng P, Chan DW. A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis [J]. Proteomics, 2003, 3(3): 243-8.
  • 6Rui Z, Guo JJ, Yuan-PT, et al. Use of serological proteomic methods to find biomarkers associated with breast cancer [J]. Proteomics,2003, 3(4): 433-9.
  • 7Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer [ J ]. Clin Chem, 2002, 48(8): 1296-304.
  • 8Gorg A, Postel W, Gunther S. The current state of two-dimensional electrophoresis with immobilized pH gradients [ J ]. Electrophoresis,2000, 21(6): 1037-53.
  • 9Mortz E, Krogh TN, Vorum H, et al. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis [ J ].Proteomics,2001, 1(11): 1359-63.
  • 10Adkins JN, Varnum SM, Auberry KJ, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry [J]. Mol Cell Proteomics, 2002, 1 (12):947-55.

共引文献13

同被引文献21

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部